About the APPOSITION
V Study APPOSITION
V is a prospective, multi-center, randomized, two-arm clinical trial to evaluate the safety and effectiveness of the STENTYS Self-Apposing[R] Stent in the treatment of de novo stenotic lesions in coronary arteries in 880 patients undergoing primary revascularization due to ST-elevation myocardial infarction (STEMI) as compared to the Multi-Link Vision[TM] coronary system (Abbott Vascular, Inc.
In the APPOSITION
III clinical trial, STENTYS stents demonstrated a very low one-month 30-day mortality rate among 1,000 high-risk AMI patients when compared to recent studies with conventional stents.
STENTYS stents have shown a very low one-month mortality rate amongst 1,000 high-risk AMI patients in the APPOSITION
III clinical trial.
STENTYS Self-Apposing[R] stent showed very low mortality at one month in 1,000 high risk heart attack patients in the APPOSITION
III study .
Following the excellent results from the APPOSITION
III study, we are going to add the Sirolimus-eluting stent to our portfolio and combine the best stent platform with a proven drug from the 'limus' family," said Gonzague Issenmann, CEO and co-founder of STENTYS.
System -- Steerable Flex Trocar with Rotary Access Needle -- Flexible Bipolar Hemostasis Forceps -- Flexible Maryland Dissector -- Articulating Hook Knife -- Articulating Snare -- Articulating Needle Knife -- Articulating Graspers -- Articulating Biopsy Forceps About NOTES and SSL
STENTYS expects to release the primary endpoint interim results of the APPOSITION
III study in 600 patients during Q4 2012, and the full results on 1,000 patients in H1 2013.
This drive to improve patient outcomes, and confirm proper stent expansion and apposition
is driving the increased use of detailed imaging modalities like IVUS.
New Touchpad Enables Physicians to Control IVUS Directly From the Sterile Field and Quickly Confirm Optimal Stent Expansion and Apposition
The new platform is very deliverable and enables easy access to distal and tortuous anatomies; it also provides excellent strut apposition
to the vessel wall," said Dr.
The study showed that the STENTYS Self-Apposing Stent enabled the perfect apposition
of these stents when treating patients with AMI.
PA), a medical technology company that is commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the 500-patient target of the international APPOSITION
III study for its Self-Apposing Stent.